Jove
Visualize
Contact Us

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

4.7K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.7K
Neural Regulation01:37

Neural Regulation

44.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.0K
Fusion of Secretory Vesicles with the Plasma Membrane01:26

Fusion of Secretory Vesicles with the Plasma Membrane

19.2K
Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
19.2K
Postsynaptic Potential (PSP)01:32

Postsynaptic Potential (PSP)

8.0K
Postsynaptic potential (PSP) refers to a change in the electrical potential of a neuron when neurotransmitters released by presynaptic neurons bind to postsynaptic receptors. This potential can either be excitatory, leading to depolarization and ultimately action potential generation, or inhibitory, leading to hyperpolarization and suppression of the postsynaptic neuron.
There are two types of receptors: ionotropic and metabotropic.
The ionotropic receptor is the membrane protein that has an...
8.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synaptic vesicle-omics in mice captures signatures of aging and synucleinopathy.

Nature communications·2025
Same author

N-acetylation of α-synuclein enhances synaptic vesicle clustering mediated by α-synuclein and lysophosphatidylcholine.

eLife·2024
Same author

Research Priorities on the Role of α-Synuclein in Parkinson's Disease Pathogenesis.

Movement disorders : official journal of the Movement Disorder Society·2024
Same author

VAMP2 chaperones α-synuclein in synaptic vesicle co-condensates.

Nature cell biology·2024
Same author

N-acetylation of α-synuclein enhances synaptic vesicle clustering mediated by α-synuclein and lysophosphatidylcholine.

bioRxiv : the preprint server for biology·2024
Same author

Disease-linked mutations in Munc18-1 deplete synaptic Doc2.

Brain : a journal of neurology·2024
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Mar 14, 2026

An Optical Assay for Synaptic Vesicle Recycling in Cultured Neurons Overexpressing Presynaptic Proteins
09:33

An Optical Assay for Synaptic Vesicle Recycling in Cultured Neurons Overexpressing Presynaptic Proteins

Published on: June 26, 2018

8.0K

New insights into synaptic vesicle dysfunction in Parkinson's disease.

Julita Chlebowicz1, Violetta Ivanova1, Jacqueline Burré1

  • 1Brain and Mind Research Institute, Appel Alzheimer's Disease Research Institute, Weill Cornell Medicine, New York, NY 10021, USA.

Journal of Parkinson'S Disease
|March 13, 2026
PubMed
Summary

Synaptic vesicle (SV) dysfunction is a key factor in Parkinson's disease (PD) pathology, affecting neurotransmitter transport and release. Targeting these early synaptic changes offers a promising therapeutic avenue for PD.

Keywords:
Parkinson's diseaseendocytosisexocytosisneurotransmitter releasesynapsesynaptic vesicle

More Related Videos

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration
07:46

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration

Published on: June 18, 2018

12.7K
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.4K

Related Experiment Videos

Last Updated: Mar 14, 2026

An Optical Assay for Synaptic Vesicle Recycling in Cultured Neurons Overexpressing Presynaptic Proteins
09:33

An Optical Assay for Synaptic Vesicle Recycling in Cultured Neurons Overexpressing Presynaptic Proteins

Published on: June 26, 2018

8.0K
Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration
07:46

Gait Analysis of Age-dependent Motor Impairments in Mice with Neurodegeneration

Published on: June 18, 2018

12.7K
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
06:07

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease

Published on: June 23, 2023

2.4K

Area of Science:

  • Neuroscience
  • Cell Biology
  • Genetics

Background:

  • Parkinson's disease (PD) involves progressive motor and non-motor symptoms.
  • Synaptic pathology, preceding neuronal loss, is central to PD pathogenesis.
  • PD-linked genes regulate synaptic vesicle (SV) trafficking, indicating SV dysfunction's role.

Purpose of the Study:

  • To review how SV dysfunction contributes to PD pathology.
  • To examine the effects of disease-linked proteins on the SV cycle.
  • To explore the impact of synaptic pathology on brain function and potential therapies.

Main Methods:

  • Literature review of recent studies on SV dysfunction in PD.
  • Analysis of how PD-linked proteins affect SV trafficking and the SV cycle.
  • Examination of presynaptic pathology's effects on postsynaptic plasticity and circuits.

Main Results:

  • Three critical pathogenic mechanisms identified: impaired neurotransmitter import/storage, disrupted SV pool organization, and altered SV exocytosis/endocytosis.
  • Presynaptic pathology triggers impairments in postsynaptic plasticity.
  • Circuit-level reorganization occurs across brain regions due to synaptic dysfunction.

Conclusions:

  • Presynaptic SV dysfunction is a central mechanism in PD pathogenesis.
  • Understanding these synaptic changes is crucial for developing PD therapies.
  • Targeting early synaptic alterations presents a promising therapeutic strategy for Parkinson's disease.